STATA RAY

Director STATA RAY sold 6,250 shares of Analog Devices for $1,996,230.65 across 11 transactions on Mar 10-11 at blended avg $319.40.

STATA RAY executed 11 separate sales totaling 6,250 shares for $1,996,230.65 over two consecutive trading days at prices ranging from $317.38 to $323.14, yielding a blended average price of $319.40. The transaction reduced his holdings from 127,857 shares to 121,607 shares (-4.9%). At the current price of $307.27, the stock is -14.8% from the 52-week high of $360.80 and down -5.5% over the prior 30 days, though up +10.0% over 90 days. His prior five sales at Analog Devices on 2026-02-05 showed modestly negative returns over 30 days (ranging from -2.7% to +0.3%), and his cross-ticker track record across 20 prior sells averaged -1.1% 30-day returns. The filing reveals a director reducing exposure—a routine rebalancing-scale reduction in a single-digit percentage of holdings—during a period when the stock has pulled back from recent highs but remains substantially elevated versus its 52-week low.

Director STATA RAY sold 6,250 shares of ADI in 21 transactions for $1,996,200.87, reducing stake to 120,696 shares

STATA RAY, a Director at Analog Devices, executed 21 separate sales totaling 6,250 shares for $1,996,200.87 across February 4–5, 2026, at prices ranging from $313.21 to $326.44. This represents a 4.9% reduction in his holdings from 126,946 to 120,696 shares. The sale activity occurred near the 52-week high of $322.12 (current price $320.45 is -0.5% from peak), with the blended average transaction price of $319.39 capturing sales distributed across a narrow 13-point price range during a period when ADI stock has appreciated 9.4% over 30 days and 40.2% over 90 days. The multiple tranches and price progression suggest a structured liquidation rather than an opportunistic single trade, though without a 10b5-1 plan FLAG this timing context is observable. Director share sales warrant monitoring given the stock's strong recent momentum and elevated P/E of 60.58, though post-transaction holdings of 120,696 shares suggest material retained interest in the company.

Director Stata Ray sold 6,250 shares at ADI for $1.9M across 12 transactions (2026-01-13–01-14), blended avg $296.44; stock at $302.10 near 52-week high.

Stata Ray, a director at Analog Devices, executed 12 separate sell transactions totaling 6,250 shares for $1,852,754.18 over two trading days, reducing holdings from 133,196 shares to 126,946 shares (a 4.7% reduction). The sales occurred at prices ranging from $293.98 to $301.90 per share, with a blended average of $296.44, while the current stock price sits at $302.10, near the 52-week high of $302.10. ADI has demonstrated strong fundamentals with annual revenue growth of 16.9%, though the stock trades at a relatively elevated P/E of 57.11. The timing of these sales relative to the company's recent price momentum—the stock is up 8.5% over 30 days and 24.4% over 90 days—warrants tracking, though no scheduled trading plan flag is noted. Investors should monitor whether this represents a one-time liquidity event or a pattern of insider activity at this price level.

Director STATA RAY sold 6,250 shares at blended avg $276.45 on Dec 16-17, retaining 133,196 shares post-sale.

STATA RAY, a director of Analog Devices, executed 13 separate sales totaling 6,250 shares for $1,727,804.08 across two trading days (December 16-17, 2025) at prices ranging from $270.92 to $281.09. This represents a 4.5% reduction in his ADI holdings, leaving him with 133,196 shares post-transaction. The blended average transaction price of $276.45 is slightly above the current price of $274.92 and well within the 52-week range of $164.60–$283.39. His five prior sales at ADI (all on 2025-11-05) showed strong 30-day performance (+18.2% to +20.9%), though 90-day outcome data is not yet available for those trades. The current filing's sale timing, at near the 52-week high (-3.0% from peak), follows a period of strong price momentum: the stock has gained 19.5% over 30 days and 12.1% over 90 days. No scheduled trading plan (10b5-1) flag is indicated, suggesting this was discretionary.

Director Stata Ray sold 6,250 shares at $232.86 average over Nov 4-5 ($1.5M); still holds 139,446 shares post-sale.

Stata Ray, a director at Analog Devices, executed 12 separate sales totaling 6,250 shares for $1,455,357.01 across November 4-5, 2025, reducing his holdings from 145,696 shares to 139,446 shares (a -4.3% reduction). The sales occurred at prices ranging from $229.45 to $238.00, with a blended average of $232.86, very close to the current price of $232.88. This multi-tranche execution across two trading days is noteworthy given that Stata Ray's prior trades at ADI (five recorded sales in October 2025) showed consistent short-term weakness, with 30-day returns of -3.7%, -3.0%, -3.4%, -3.6%, and -4.0%. The broader context shows ADI trading at 58.51 P/E with annual revenue declining 23.4% year-over-year, suggesting the company is navigating a significant demand contraction. The director's ongoing, measured liquidation pattern at ADI warrants monitoring as a potential signal of internal sentiment regarding near-term price dynamics.

Director Stata Ray sells 6,250 shares at blended avg $241.64; retains 145.7K shares post-sale

Stata Ray, a Director at Analog Devices, executed 11 separate sales totaling 6,250 shares for $1,510,267.87 on October 1–2, 2025, at prices ranging from $236.98 to $245.28 and a blended average of $241.64. This represents a -4.1% reduction against his pre-transaction holdings of 151,946 shares, leaving him with 145,696 shares. The current stock price of $241.99 sits -5.3% from its 52-week high of $255.63 and has declined -1.0% over 30 days and -1.5% over 90 days. Ray's cross-ticker track record shows 20 prior open-market sells with an average 30-day return of +8.5%, though his five recent same-ticker trades at ADI (all sales on September 17–18, 2025) have measurable outcomes not yet complete. Analog Devices is trading at a P/E of 60.80 with an annual revenue decline of -23.4% and fundamentals showing $2.9B quarterly revenue and $518.5M net income. The sequential nature and modest portfolio reduction warrant observation but do not signal material conviction shift.

Director STATA RAY sold 6,250 shares at blended $248.27 for $1.6M on 2025-09-17/18

STATA RAY executed 9 separate sales totaling 6,250 shares for $1,551,663.41 across September 17-18, with transaction prices ranging from $245.15 to $251.49. The blended average price of $248.27 sits 0.94 above the current price of $245.33 and only 3.0 points below the 52-week high of $255.63, indicating the shares were sold in a relatively strong price environment. Post-sale, he retains 151,946 shares, representing a -4.0% reduction in holdings. His same-ticker history at ADI shows five recent sales in early August, all of which posted double-digit positive 30-day returns (+10.3% to +12.8%), suggesting prior sales at this stock have not preceded downside moves. The company trades at a P/E of 61.64 with annual revenue growth of -23.4%, though latest quarterly revenue stands at $2.9B and net income at $518.5M.

Director STATA RAY sold 6,250 shares (6.2K shares) of ADI for $1,378,977.10 ($1.4M) on Aug 5-6.

STATA RAY sold 6,250 shares across 9 separate transactions on August 5–6, 2025, reducing holdings by 3.8% from 164,446 to 158,196 shares. The blended average sale price was $220.64, and the current price is $223.12, placing the transaction within the stock's recent range (up 7.5% over 90 days but down 9.0% over 30 days and down 9.2% from the 52-week high of $245.68). ADI's fundamentals show an annual revenue decline of -23.4% and a P/E of 60.47, indicating a high valuation multiple against a contracting revenue base. The director maintains substantial ongoing holdings of 158,196 shares post-transaction, and this sale immediately follows multiple sells on July 16–17, 2025 at the same company; however, outcomes from those prior trades are not yet measurable.

Director STATA RAY sold 6,250 shares of ADI for $1.5M across 8 transactions; post-sale holding 164,446 shares.

STATA RAY, a director at Analog Devices, executed 8 separate sales totaling 6,250 shares for $1,500,829.63 over July 16–17, 2025, at prices ranging from $236.58 to $241.38 with a blended average of $240.13. The sale reduced holdings by 3.7% to 164,446 shares. The stock is currently at $241.85, near its 52-week high of $245.68, and has gained 5.3% over 30 days and 37.2% over 90 days. His prior trades at ADI (5 sells in early June 2025) all showed positive 30-day returns (4.8%–5.8%), with no adverse 90-day outcomes yet measurable at the time of filing. Across all tickers in his open-market history, his cross-ticker track record shows a 0.00% well-timed sell rate at the 90-day horizon, despite an average 90-day return of +38.0% across those prior sales—indicating the stock typically rose after his prior sells, making them poorly timed in hindsight. The context of strong recent price appreciation, elevated valuation (P/E 65.54), and annual revenue contraction of -23.4% alongside a pattern of prior poorly-timed sells warrants observation of whether this large director liquidation signals a shift in conviction.

Analog Devices Director Stata Ray sold 6,250 shares for $1,453,537.50 across two days (6/11–6/12) at blended $232.57, now trading at $225.03.

Stata Ray, a director at Analog Devices, executed 8 separate sales totaling 6,250 shares for $1,453,537.50 on June 11–12, at a blended average price of $232.57. The current stock price of $225.03 is 7.7% below the 52-week high of $243.82, and the insider remains a substantial shareholder with 170,696 shares post-transaction, down only 3.5% from pre-transaction holdings. Notably, Ray's prior five trades at Analog Devices (all in early May) each posted gains of 11.1% to 13.0% within 30 days, suggesting accurate recent execution at this ticker; however, these prior sales have not yet reached the 90-day measurement window, so their ultimate outcome remains unmeasurable. Against a backdrop of -23.4% annual revenue decline and elevated valuation (P/E 60.98), the sale occurs during a period of modest recent weakness (-0.8% over 30 days) but cumulative gain (+7.8% over 90 days), and does not constitute material portfolio reduction given the director retains more than 170K shares.